Skip to main content

What the FDA labels say about taking them together

Cobicistat and metoprolol

Cobicistat's FDA label of February 10, 2026 names metoprolol in its drug interactions section; the metoprolol labels PlainMeds reads (4) do not name cobicistat. The cobicistat label: “Clinical monitoring is recommended for coadministration with beta-blockers that are metabolized by CYP2D6.”

Check it at the source: the cobicistat FDA label on DailyMed (effective February 10, 2026, Gilead Sciences, Inc.); the metoprolol FDA label on DailyMed (effective March 3, 2026, Melinta Therapeutics, LLC).

What does the cobicistat label say about metoprolol?

Cobicistat label, drug interactions

Concomitant Drug Class/Drug Name: Beta-Blockers: e.g., metoprolol carvedilol timolol; Potential Effect ↑ = Increase, ↓ = Decrease, ↔ = No change: ↑ beta-blockers; Clinical Comment: Clinical monitoring is recommended for coadministration with beta-blockers that are metabolized by CYP2D6.

Source: FDA drug label (Tybost), Gilead Sciences, Inc., effective February 10, 2026 (SPL set 3784c35c-e87f-410c-900b-8fd6313c6010), via openFDA; the full label on DailyMed

What does the metoprolol label say about cobicistat?

Metoprolol's label (effective March 3, 2026) and its 3 other brand-application labels do not name cobicistat in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (TOPROL XL), Melinta Therapeutics, LLC, effective March 3, 2026 (SPL set 496ddfaa-7c9c-4888-b747-a210249b367a), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Cobicistat generic labelers
74Metoprolol generic labelers
CobicistatMetoprolol
Labeled forHIVHigh blood pressure, Angina, Heart failure, Heart attack and coronary artery disease
Boxed warningNoNo
Pharmacy cost (NADAC)n/a$0.085 per tablet 100 mg tablet
Shortage nowA presentation being discontinuedA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?